News

From January 30 to February 2, 2026, the Scientific Council of the FGBI "ARRIAH" held meetings where they reviewed and approved the research plans for 2026.

During the meeting, plans were presented for developing methodological guidelines, diagnostic tools, and vaccines aimed at ensuring animal disease freedom and epizootic safety, advancing domestic technologies, and promoting import substitution.

Key efforts include creating two methodologies: one for assessing antibody levels in animals vaccinated against leptospirosis, and another for diagnosing Aujeszky's disease. The latter will form the basis for a GOST R draft, leading to a new regulatory standard for controlling this disease. For the first time, a methodology will be developed for detecting carboxy- and ureidopenicillins in food products using HPLC-MS, along with two new methods for detecting dangerous pathogens (Staphylococcus spp, Listeria monocytogenes) in feeds and food raw materials. Additionally, it is planned to develop two FMD vaccines targeting different genetic lines of serotypes O and SAT-1.

For cattle and small ruminants in 2026, the plans include:

-         conducting preclinical studies of a vaccine against bovine pasteurellosis and histophilosis;

-         finalizing a combined vaccine against bovine parainfluenza-3, infectious bovine rhinotracheitis, bovine viral diarrhea, and bovine respiratory syncytial virus;

-         developing a test kit based on recombinant proteins for serological diagnosis of highly dangerous infections of small ruminants;

-         developing test kits for detecting antibodies to Mycoplasma bovis and bovine parainfluenza-3 using ELISA;

-         developing a test kit for detecting the caprine arthritis encephalitis virus genome using real-time PCR.

For the swine industry, the focus is on:

-         developing a test kit for detecting RNA of hepatitis E virus genotype 3 using real-time PCR;

-         creating methodological guidelines for differentiating African swine fever virus variants using PCR;

-         developing methodological guidelines for isolation of classical swine fever virus in continuous cell lines, with identification of viral replication by real‑time RT‑PCR.

To diagnose and monitor poultry diseases in 2026, the following will be developed:

-         a chicken infectious anemia vaccine;

-         a live dry vaccine against duck viral hepatitis;

-         a PCR test kit for detecting RNA of Newcastle disease virus genotype VII;

-         a kit for detecting antibodies to the avian reovirus pathogen using ELISA;

-         methodological guidelines for detecting fowl adenovirus serotype 8 antigen via indirect liquid-phase blocking ELISA;

-         guidelines for detecting antibodies to chicken infectious anemia virus;

-         guidelines for differentiating field isolates and strains of fowl adenovirus species E using PCR and Fiber protein gene sequencing;

-         methodological guidelines for evaluating the effectiveness of biosafety systems at poultry farming and breeding facilities.

Special attention will be given to aquaculture: Center scientists will develop a PCR-based method for detecting RNA of infectious hematopoietic necrosis virus—a disease causing major losses in fish farms worldwide. This method will enable control during imports of roe and fish seed stock from abroad and support Russian exports. Currently, no rapid diagnostic procedures exist in Russia for this disease, making the development of such a test a relevant task.

For pet animals, the FGBI "ARRIAH" plans to develop:

-         methodological guidelines for inactivating feline calicivirus;

-         guidelines for inactivating feline viral rhinotracheitis virus.

In 2026, scientists at the FGBI "ARRIAH" will continue research on detecting pathogens of transboundary animal diseases, studying their biological properties, collecting and analyzing epizootiological data to assess risks of introduction and spread of highly dangerous animal diseases, maintaining Russia's disease-free status in accordance with the WOAH Terrestrial Animal Health Code requirements, and in other key areas to support national disease freedom.